U.S. Multiple Sclerosis Markets

U.S. Multiple Sclerosis Markets

 

RELEASE DATE
25-Sep-2007
REGION
North America
Research Code: N168-01-00-00-00
SKU: HC02032-NA-MR_07347
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02032-NA-MR_07347
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research service provides revenue forecasts, market shares, projected prevalence and treated populations, market trends, and existing and emerging therapeutics. There is a competitive and product analysis of the major market participants and products with competitive metrics for major and emerging companies.

Table of Contents

Introduction

  • Multiple Sclerosis
  • Scope and Segmentation
  • Research Methodology

Disease Overview

  • Causes of Multiple Sclerosis
  • Classification of Multiple Sclerosis
  • Treatment Options

Market Overview

  • Market Engineering Measurements
  • Market Trends

Product Analysis

Patient Forecasts

Revenue Forecasts

  • Interferons
  • Copaxone
  • Tysabri
  • Novantrone
  • Pipeline Drugs

Competitive Analysis

  • Total Patient Forecasts
  • Patient Forecast by Product

Competitve Metrics

  • Total Market Revenue Forecasts
  • Revenue Forecasts by Product

Demographic Indicators

Market Indicators

This research service provides revenue forecasts, market shares, projected prevalence and treated populations, market trends, and existing and emerging therapeutics. There is a competitive and product analysis of the major market participants and products with competitive metrics for major and emerging companies.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N168-01-00-00-00
Is Prebook No